ストックスクリーナーアプリを入手
15.03
2.80%
0.41
Alpha Tau Medical Ltd (DRTS) 最新ニュース
Alpha Tau Medical (DRTS) officer schedules next stock sale under 10b5-1 plan - Stock Titan
Alpha Tau Medical (NASDAQ:DRTS) Sets New 1-Year HighHere's What Happened - MarketBeat
Alpha Tau Medical stock hits 52-week high at 14.79 USD - Investing.com
Alpha Tau’s Clinical Momentum Put Its Cancer Tech On The Map - Finimize
Price to sales forward of Alpha Tau Medical Ltd. – NASDAQ:DRTSW - TradingView
Price to earnings forward of Alpha Tau Medical Ltd. – NASDAQ:DRTSW - TradingView
DRTS Stock Gets A Pre-Market Boost – Retail Shrug Off Wider Q1 Loss Ahead Of Key Pancreatic Cancer Data Reveal This Week - Stocktwits
Price to earnings forward of Alpha Tau Medical Ltd. – BOATS:DRTSW - TradingView
DRTS Stock Price, Quote & Chart - ChartMill
Is Alpha Tau Medical’s (DRTS) Steepening Loss Curve Reframing Its High-Risk Innovation Strategy? - simplywall.st
Alpha Tau Medical Ltd.: Fundamental Analysis and Financial Ratings | DRTS | IL0011839383 - marketscreener.com
Alpha Tau Medical (XTAE:DRTS) Cyclically Adjusted Price-to-FCF : (As of Aug. 15, 2026) - GuruFocus
Alpha Tau Medical (XTAE:DRTS) Shiller PE Ratio : (As of Aug. 21, 2026) - GuruFocus
DRTS Forecast — Price Target — Prediction for 2027 - TradingView
Q3 EPS Estimate for Alpha Tau Medical Decreased by Analyst - MarketBeat
Alpha Tau Medical (NASDAQ:DRTS) Stock Price Down 5.4% Following Insider Selling - MarketBeat
Alpha Tau Medical (NASDAQ:DRTS) CFO Sells $248,220.00 in Stock - MarketBeat
H.C. Wainwright raises Alpha Tau Medical stock price target to $16 - Investing.com
Five Takeaways from AHNS 2026: Alpha DaRT in Combination with Immunotherapy for Advanced Head and Neck Cancer - Alpha Tau Medical
ALPHA TAU MEDICAL LTD. : H.C. WAINWRIGHT RAISES TARGET PRICE TO $16 FROM $15 - webull.com
Alpha Tau Medical (DRTS) Clinical Progress Tests Whether The Stock Already Looks Fully Valued - simplywall.st
Alpha Tau Medical stock hits 52-week high at 14.12 USD - Investing.com India
Alpha Tau Medical Ltd Cash Flow – TASE:DRTS - TradingView
Price to sales forward of Alpha Tau Medical Ltd – TASE:DRTS - TradingView
Free cash flow per share of Alpha Tau Medical Ltd – TASE:DRTS - TradingView
Alpha Tau Medical (NASDAQ:DRTS) Hits New 12-Month High Following Analyst Upgrade - MarketBeat
Price to sales ratio of Alpha Tau Medical Ltd – TASE:DRTS - TradingView
Enterprise value to revenue forward of Alpha Tau Medical Ltd – TASE:DRTS - TradingView
Enterprise value to EBITDA forward of Alpha Tau Medical Ltd – TASE:DRTS - TradingView
Operating expenses (excl. COGS) of Alpha Tau Medical Ltd – TASE:DRTS - TradingView
Alpha Tau Medical Ltd Balance Sheet – TASE:DRTS - TradingView
Preferred dividends of Alpha Tau Medical Ltd – TASE:DRTS - TradingView
H.C. Wainwright Maintains Alpha Tau Medical(DRTS.US) With Buy Rating, Raises Target Price to $16 - moomoo.com
HC Wainwright Issues Positive Forecast for Alpha Tau Medical (NASDAQ:DRTS) Stock Price - MarketBeat
Alpha Tau Medical Ltd. (DRTS) stock price, news, quote and history - Yahoo Finance UK
Alpha Tau Medical Ltd. (DRTS) Stock Price, News, Quote & History - Yahoo! Finance Canada
Alpha Tau Medical Reports H1 2026 Results Amid Major Clinical and Commercial Milestones - scanx.trade
Alpha Tau Announces Second Quarter 2026 Financial Results and Provides Corporate Update - Alpha Tau Medical
Alpha Tau Medical (NASDAQ:DRTS) Releases Earnings Results, Misses Estimates By $0.36 EPS - MarketBeat
Alpha Tau Medical (DRTS) widens loss as Tolmar deal boosts cash and milestones - stocktitan.net
Alpha Tau Medical Files for Dual Listing on Tel Aviv Stock Exchange - marketscreener.com
Alpha Tau Registers for Dual Listing on the Tel Aviv Stock Exchange (TASE) - Caledonian Record
Alpha Tau Medical (NASDAQ: DRTS) moves to dual-list shares on TASE - Stock Titan
Alpha Tau Medical (NASDAQ:DRTS) Stock Rating Upgraded by Zacks Research - MarketBeat
Alpha Tau Medical (DRTS) Expected to Post Earnings on Monday - MarketBeat
Why Alpha Tau Medical (DRTS) Is Down 5.7% After Early-Stop Alpha DaRT Trial SuccessAnd What's Next - simplywall.st
Alpha Tau Medical Ltd. (NASDAQ:DRTS) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Alpha Tau Medical (DRTS) Is Down 5.7% After Early-Stop Success In Alpha DaRT Combo Trial - Yahoo Finance
Alpha Tau Medical Ltd. Revenue Breakdown – NASDAQ:DRTSW - tradingview.com
DRTS|Alpha Tau Medical Ltd|Price:12.200|Chg%:-0.300 - TradingKey
Alpha Tau Medical Ltd (DRTS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Alpha Tau Medical (DRTS) Clinical Win Puts Its Pricey Valuation Back In Focus - simplywall.st
0.86%
0.31%
大文字化:
|
ボリューム (24 時間):